Global Markets for Diabetes Therapeutics and Diagnostics
The global diabetes market should reach $155 billion by 2021 from $125 billion in 2016 at a compound annual growth rate (CAGR) of 4.4%, from 2016 to 2021.
This report provides:
An overview of the global market for diabetes
Analyses of global market trends, with data from 2015, estimates for 2016, and projections of CAGRs through 2021.
Analysis of the devices and instruments used in the diagnosis and monitoring of diabetes
A close look at major forces contributing to the vigorous growth of the diabetes market
Evaluation of other factors influencing the market such as health care policies, demographics, and the wider economic environment
Discussion covering companies in the relevant pharmaceutical and medical industries through company profiles of many leading players in the field
This report discusses the implications of the above-mentioned trends, in the context of the current size and growth of the diabetes market, in global terms as well as by the most important national markets. Companies in the relevant pharmaceutical and medical industries are discussed, with profiles of the leaders and an update on M&A activity. Five-year global sales forecasts are provided for the main drug and device categories, and breakdowns of the diabetes market are provided by country.
A comprehensive refresher section on diabetes is provided as an appendix.